Palvella CEO to Pitch Rare-Disease Pipeline at Investor Meets
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Executive Officer Wes Kaupinen will appear at two healthcare investor conferences in September, giving investors two near-term opportunities to hear from …
Palvella CEO to Pitch Rare-Disease Pipeline at Investor Meets Read More